Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 276.05%1.42B | 220.25%693.49M | 321.52%764.07M | 177.10%3.3B | 27.92%-807.81M | 17.60%-576.7M | 27.32%-344.93M | -238.47%-4.29B | -2.99%-1.12B | 6.50%-699.92M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | 415.45%347K | ---- | ---- | ---- | -101.11%-110K | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -100.43%-13.17M | ---- | ---- | ---- | 13,262.03%3.03B | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -100.43%-13.17M | ---- | ---- | ---- | 13,262.03%3.03B | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -85.60%-31.67M | ---- | ---- | ---- | -13.55%-17.06M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.01M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -162.76%-31.67M | ---- | ---- | ---- | 19.79%-12.05M | ---- | ---- |
| Depreciation and amortization: | 7.08%2.64B | 8.24%1.77B | 8.64%888.32M | -4.43%3.35B | -9.73%2.47B | -9.67%1.63B | -7.93%817.66M | 4.94%3.51B | 9.96%2.74B | 8.13%1.81B |
| -Depreciation | 8.29%2.57B | 8.87%1.71B | 9.44%856.52M | -3.72%3.24B | -8.70%2.38B | -8.38%1.57B | -7.20%782.67M | 5.63%3.37B | 9.92%2.6B | 9.16%1.72B |
| -Other depreciation and amortization | -24.05%70.2M | -8.47%53.97M | -9.09%31.8M | -21.26%110.72M | -29.96%92.43M | -34.42%58.97M | -21.72%34.98M | -9.22%140.63M | 10.71%131.98M | -8.43%89.92M |
| Special items | -606.37%-1.71B | -437.62%-882M | -695.75%-959.16M | -859.27%-3.85B | 24.28%337.59M | 71.50%261.24M | 91.16%161M | 472.84%507.03M | -6.74%271.64M | -22.68%152.33M |
| Operating profit before the change of operating capital | 17.89%2.36B | 19.86%1.58B | 9.39%693.23M | 0.66%2.76B | 5.98%2B | 4.55%1.32B | 27.34%633.73M | 25.70%2.75B | 11.57%1.89B | 12.49%1.26B |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -525.34%-665.88M | ---- | ---- | ---- | 84.31%-106.48M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 150.65%88.38M | ---- | ---- | ---- | -46.74%35.26M | ---- | ---- |
| Cash from business operations | 17.89%2.36B | 19.86%1.58B | 9.39%693.23M | -18.26%2.19B | 5.98%2B | 4.55%1.32B | 27.34%633.73M | 68.22%2.67B | 11.57%1.89B | 12.49%1.26B |
| Other taxs | ---- | ---- | ---- | 70.17%-115.81M | ---- | ---- | ---- | -132.84%-388.28M | ---- | ---- |
| Special items of business | 102.50%24.78M | 107.01%66.6M | 111.45%86.84M | 40.28%-131.69M | -28.50%-990.26M | -45.11%-949.54M | -21.03%-758.7M | -356.64%-220.51M | -397.21%-770.61M | -357.12%-654.37M |
| Net cash from operations | 136.03%2.38B | 347.62%1.65B | 724.20%780.07M | -6.14%1.94B | -9.57%1.01B | -39.29%367.55M | 3.26%-124.97M | -27.74%2.07B | -42.78%1.12B | -55.95%605.42M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---- | ---- | ---- | 214.90%1.17B | ---- | ---- | ---- | ---1.02B | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | 998.32%203.9M | ---- | ---- | ---- | -57.44%18.57M | ---- | ---- |
| Purchase of fixed assets | -43.03%-3.7B | -26.63%-2.27B | -7.03%-1.01B | 0.77%-3.17B | 47.65%-2.58B | 48.06%-1.8B | 53.82%-943.03M | 59.30%-3.19B | 12.93%-4.94B | 11.49%-3.46B |
| Sale of subsidiaries | ---- | ---- | ---- | 65.04%39M | ---- | ---- | ---- | --23.63M | ---- | ---- |
| Cash on investment | 105.40%2.26B | -50.80%540.19M | 12.02%-360.09M | 63.73%-85.19M | 564.38%1.1B | 870.82%1.1B | -170.59%-409.28M | 93.27%-234.85M | 93.20%-236.45M | 95.40%-142.45M |
| Other items in the investment business | ---- | ---- | ---- | -135.33%-6.92B | ---3.91B | ---1.8B | ---652.08M | -15,571.37%-2.94B | ---- | ---- |
| Net cash from investment operations | 73.30%-1.44B | 30.54%-1.73B | 31.68%-1.37B | -19.30%-8.76B | -4.31%-5.4B | 30.65%-2.5B | 8.62%-2B | 34.87%-7.34B | 43.44%-5.17B | 48.61%-3.6B |
| Net cash before financing | 121.46%941.08M | 95.83%-88.74M | 72.32%-589.34M | -29.25%-6.82B | -8.13%-4.39B | 28.91%-2.13B | 8.32%-2.13B | 37.29%-5.28B | 43.61%-4.06B | 46.82%-2.99B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | 6.59%6.66B | ---- | ---- | ---- | -47.48%6.24B | ---- | ---- |
| Refund | ---- | ---- | ---- | -4.87%-6.03B | ---- | ---- | ---- | 40.05%-5.75B | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.25%3.93B | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | -0.46%-54.17M | ---- | ---- | ---- | -4.55%-53.92M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 97.63%-54.78M | ---- | ---- | ---- | -2,016.06%-2.32B | ---- | ---- |
| Other items of the financing business | -26.18%4.6B | 26.44%5.42B | -86.46%275.03M | 452.55%17.08B | 125.21%6.23B | 84.51%4.29B | -47.57%2.03B | 4,860.41%3.09B | -30.80%2.77B | -11.19%2.32B |
| Net cash from financing operations | -26.18%4.6B | 26.44%5.42B | -86.46%275.03M | 310.06%17.06B | 125.21%6.23B | 84.51%4.29B | -47.57%2.03B | -14.34%4.16B | -30.80%2.77B | -11.19%2.32B |
| Effect of rate | -539.65%-45.64M | -175.88%-15.92M | 97.56%-242K | -108.81%-13.59M | -104.77%-7.14M | -86.88%20.97M | -139.73%-9.91M | -62.93%154.3M | -64.79%149.6M | -49.52%159.82M |
| Net Cash | 200.65%5.54B | 147.06%5.33B | -220.36%-314.31M | 1,015.13%10.24B | 242.74%1.84B | 421.55%2.16B | -106.32%-98.11M | 68.59%-1.12B | 59.63%-1.29B | 77.74%-671.05M |
| Begining period cash | 2.22%8.09B | 2.22%8.09B | 2.22%8.09B | -10.85%7.92B | -10.85%7.92B | -10.85%7.92B | -10.85%7.92B | -26.15%8.88B | -26.15%8.88B | -26.15%8.88B |
| Items Period | ---- | ---87.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---598K | ---274K |
| Cash at the end | 39.31%13.59B | 31.94%13.32B | -0.40%7.78B | 129.09%18.14B | 26.00%9.75B | 20.62%10.1B | -25.31%7.81B | -10.85%7.92B | -16.35%7.74B | -10.27%8.37B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Accounting Firm | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.